In patients with stroke or TIA and CYP2C19 loss-of-function alleles, ticagrelor vs. clopidogrel reduced 90-d stroke

被引：1
|
作者：
Joundi, Raed A. [1 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
来源：
ANNALS OF INTERNAL MEDICINE | 2022年 / 175卷 / 03期
关键词：
MINOR STROKE; ASPIRIN;
D O I：
10.7326/J22-0008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：JC30 / JC30
页数：1
相关论文
共 50 条
  • [31] Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles
    Xingyang Yi
    Qiang Zhou
    Chun Wang
    Jing Lin
    Zhenxiao Chai
    Journal of Neurology, 2018, 265 : 2396 - 2403
  • [32] Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles
    Yi, Xingyang
    Zhou, Qiang
    Wang, Chun
    Lin, Jing
    Chai, Zhenxiao
    JOURNAL OF NEUROLOGY, 2018, 265 (10) : 2396 - 2403
  • [33] Clopidogrel responder status is uninfluenced by CYP2C19*2 in Danish patients with stroke
    Rath, Charlotte Lutzhoft
    Jorgensen, Niklas Rye
    Wienecke, Troels
    PLOS ONE, 2020, 15 (12):
  • [34] CYP2C19 Loss-of-Function Variants Associated With Long-Term Ischemic Stroke Events During Clopidogrel Treatment in the Chinese Population
    Wu, Peng
    Liu, Ziqing
    Tian, Zijian
    Wu, Benrui
    Shao, Jian
    Li, Qian
    Geng, Zhaoxu
    Pan, Ying
    Lu, Ke
    Wang, Qiang
    Xu, Tao
    Zhou, Kaixin
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (05) : 1126 - 1133
  • [35] Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack
    Wang, Yilong
    Zhao, Xingquan
    Lin, Jinxi
    Li, Hao
    Johnston, S. Claiborne
    Lin, Yi
    Pan, Yuesong
    Liu, Liping
    Wang, David
    Wang, Chunxue
    Meng, Xia
    Xu, Jianfeng
    Wang, Yongjun
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (01): : 70 - 78
  • [36] The effect of loss-of-function allele (CYP2C19*3) with Clopidogrel efficacy in coronary heart disease patients
    Rochmawati, Ike Dhiah
    Hidayat, Nur
    Pomantow, David
    PHARMACY EDUCATION, 2021, 21 (02): : 178 - 183
  • [37] Comparison of ticagrelor and clopidogrel in the treatment of patients with coronary heart disease carrying CYP2C19 loss of function allele
    Qian, Wenwen
    Chen, Liang
    Zhang, Lizhu
    Gao, Mingzhu
    Wang, Chunxia
    Qian, Xi
    Yang, Chengjian
    Lin, Yahui
    Han, Zhijun
    JOURNAL OF THORACIC DISEASE, 2022, : 2591 - 2601
  • [38] Investigating CYP2C19 loss-of-function allele statuses and their association with stroke of different etiologies in a Taiwanese population
    Lee, Yi-Chung
    Liao, Yi-Chu
    Chang, Feng-Chi
    Huang, Hui-Chi
    Tsai, Jui-Yao
    Chung, Chih-Ping
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (06) : 469 - 472
  • [39] Role of CYP2C19 alleles in the management of recurrent ischemic stroke
    Lyerly, Michael J.
    Bartlett, Kelly
    Albright, Karen C.
    NEUROLOGY-CLINICAL PRACTICE, 2019, 9 (02) : 140 - 144
  • [40] Paraoxonase-1 activity affects the clopidogrel response in CYP2C19 loss-of-function carriers
    Nishio, Ryo
    Shinke, Toshiro
    Otake, Hiromasa
    Nakagawa, Masayuki
    Inoue, Takumi
    Hariki, Hirotoshi
    Osue, Tsuyoshi
    Taniguchi, Yu
    Iwasaki, Masamichi
    Hiranuma, Noritoshi
    Konishi, Akihide
    Kinutani, Hiroto
    Kuroda, Masaru
    Hirata, Ken-Ichi
    THROMBOSIS RESEARCH, 2013, 132 (05) : 558 - 564
12345